SATO KEN

Research field (1)： Hematology and oncology

Research keywords (2)： SATO K , erythropoietin

Research theme for competitive and other funds (1)：

2018 - 2021 Mechanism of myelofibrosis and extramedullary hematopoiesis by fibrocytes

Papers (62)：

久能美香, 小林彩香, 竹内英之, 齋藤寿実子, 吉田稔, 原眞純, 佐藤謙. ブリナツモマブにより長期の分子学的寛解を維持している高齢者再発Ph陽性急性リンパ芽球性白血病. 日本内科学会関東地方会. 2022. 681回. 49-49
Kotaro Matsumoto, Kentaro Kikuchi, Tomohiro Kikuyama, Go Saito, Takako Adachi, Ayako Watanabe, Hiromichi Tsunashima, Takayuki Tsujikawa, Ken Sato, Shinpei Doi. Disseminated Bone Marrow Carcinomatosis Due to Malignant Melanoma of Unknown Primary Origin. Internal medicine (Tokyo, Japan). 2021. 60. 21. 3469-3472
寺本昌弘, 曽根岳大, 高田耕平, 小縣開, 齋藤啓太, 和泉拓野, 高野昂佑, 長尾茂輝, 岡田陽介, 田地規朗, et al. 当院におけるbendamustine、rituximab併用療法の後方視的検討. 臨床血液. 2020. 61. 6. 598-604
成山倫之, 大谷津翔, 菊池健太郎, 佐藤謙, 吉田稔. 急性骨髄性白血病の化学療法中におけるRothia mucilaginosaによる菌血症の1例. 感染症学雑誌. 2020. 94. 2. 269-269
Masahiro Teramoto, Takehiro Sone, Kohei Takada, Hiraku Ogata, Keita Saito, Takuya Izumi, Kosuke Takano, Shigeki Nagao, Yosuke Okada, Noriaki Tachi, et al. [Bendamustine and rituximab combination therapy for recurrent indolent B-cell lymphomas: a retrospective single-institution study]. [Rinsho ketsueki] The Japanese journal of clinical hematology. 2020. 61. 6. 598-604

ｍore...

MISC (197)：

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page